Chemopreventive Agent 3,3′-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells

Chemopreventive Agent 3,3′-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells

3,3′-Diindolylmethane (DIM) is a naturally derived chemopreventive compound. It comes from glucobrassicin, an indole glucosinolate enriched in cruciferous vegetables, and is formed in the acidic environment of the stomach after ingestion. Mouse double minute 2 homolog (MDM2) is an important, multi-f...

Full description

Bibliographic Details
Main Authors:	Xiang Gao, Jingwen Liu, Kwang Bog Cho, Samanthreddy Kedika, Bin Guo
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	International Journal of Molecular Sciences
Subjects:	3,3′-Diindolylmethane MDM2 colorectal cancer p53 cancer prevention
Online Access:	https://www.mdpi.com/1422-0067/21/13/4642

Similar Items

The Effect of Indole-3-Carbinol and 3,3'-Diindolylmethane on Fatty Acid Synthase and Sp1 in Breast Cancer Cells
by: Saati, George
Published: (2009)

The Effect of Indole-3-Carbinol and 3,3'-Diindolylmethane on Fatty Acid Synthase and Sp1 in Breast Cancer Cells
by: Saati, George
Published: (2009)

Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal Cancer
by: Soo Mi Kim
Published: (2016-07-01)

Therapeutic effects of 3,3′-diindolylmethane on the alveolar bone in mice with experimentally induced periodontitis
by: Jingjing Pan, et al.
Published: (2018-05-01)

Interactions between β-Lactoglobulin and 3,3′-Diindolylmethane in Model System
by: Cuina Wang, et al.
Published: (2019-06-01)

Physicochemical and Microstructural Properties of Polymerized Whey Protein Encapsulated 3,3′-Diindolylmethane Nanoparticles
by: Abbas Khan, et al.
Published: (2019-02-01)

A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth
by: Yin Xiao-Fei, et al.
Published: (2012-05-01)

3,3′-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice
by: Tai-yong Yu, et al.
Published: (2015-01-01)

3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs
by: Hui Shi, et al.
Published: (2021-03-01)

3,3′-Diindolylmethane ameliorates renal fibrosis through the inhibition of renal fibroblast activation in vivo and in vitro
by: Zun-En Xia, et al.
Published: (2018-10-01)

Iodine-catalyzed electrophilic substitution of indoles: Synthesis of (un)symmetrical diindolylmethanes with a quaternary carbon center
by: Thanigaimalai Pillaiyar, et al.
Published: (2021-06-01)

3,3′-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway
by: Bo-Gyoung Kim, et al.
Published: (2018-01-01)

Exogenous 3,3′-Diindolylmethane Improves Vanadium Stress Tolerance in <i>Brassica napus</i> Seedling Shoots by Modulating Antioxidant Enzyme Activities
by: Arun Gokul, et al.
Published: (2021-03-01)

Elucidating the Role of CD84 and AHR in Modulation of LPS-Induced Cytokines Production by Cruciferous Vegetable-Derived Compounds Indole-3-Carbinol and 3,3′-Diindolylmethane
by: Thomas T. Y. Wang, et al.
Published: (2018-01-01)

Anti-Cancer and Other Biological Effects of a Dietary Compound 3,3ʹ-Diindolylmethane Supplementation: A Systematic Review of Human Clinical Trials
by: Amare DE
Published: (2020-08-01)

Molecular simulation studies of 3,3′-Diindolylmethane as a Potent MicroRNA-21 Antagonist
by: Md Junaid, et al.
Published: (2017-01-01)

Anti-Cancer Effects of 3, 3’-Diindolylmethane on Human Hepatocellular Carcinoma Cells Is Enhanced by Calcium Ionophore: The Role of Cytosolic Ca2+ and p38 MAPK
by: Yuanyue Jiang, et al.
Published: (2019-10-01)

Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
by: Kandala Prabodh K, et al.
Published: (2012-01-01)

Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane
by: David E. Williams
Published: (2021-10-01)

Copper Ferrite Superparamagnetic Nanoparticle-Catalyzed Cross-coupling Reaction to Form Diindolylmethane (DIM): Effect of Experimental Parameters
by: Oanh T.K. Nguyen, et al.
Published: (2020-12-01)

Clinical overview of MDM2/X targeted therapies
by: Andrew eBurgess, et al.
Published: (2016-01-01)

Molecular target based combinational therapeutic approaches in thyroid cancer
by: Rajoria Shilpi, et al.
Published: (2012-05-01)

Preparation and Characterization of Whey Protein Isolate–DIM Nanoparticles
by: Abbas Khan, et al.
Published: (2019-08-01)

MDM2-C Functions as an E3 Ubiquitin Ligase
by: Kim JY, et al.
Published: (2020-08-01)

miR‐33a inhibits cell growth in renal cancer by downregulation of MDM4 expression
by: Kehua Jiang, et al.
Published: (2019-08-01)

Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion
Published: (2007)

Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion M.
Published: (2007)

Experience of clinical use of diindolylmethane in the treatment of HPV-associated low-grade cervical lesions
by: I. I. Kutsenko, et al.
Published: (2020-04-01)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01)

Akt Regulation of Mdm2-p53 Signaling in Cellular Stress Responses and Tumorigenesis
by: Chibaya, Loretah
Published: (2019)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
by: Johanna Huun, et al.
Published: (2017-04-01)

Modern approach to tactics of management of patients with cervical intraepitital neoplasia of easy degree
by: Liudmila V. Tkachenko, et al.
Published: (2020-12-01)

Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53
by: Xin Tian, et al.
Published: (2016-10-01)

Targeting MDM4 Splicing in Cancers
by: Boris Bardot, et al.
Published: (2017-02-01)

Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
by: Agnė Bartnykaitė, et al.
Published: (2021-02-01)

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
by: Seyed Pairawan, et al.
Published: (2021-03-01)

MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail
by: Jack D. Sanford, et al.
Published: (2021-09-01)

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
by: Yuan Fang, et al.
Published: (2020-07-01)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
by: Ola A Bakry, et al.
Published: (2012-01-01)

Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma
by: Joon Hee Kang, et al.
Published: (2020-06-01)